本页面由Tiger Trade Technology Pte. Ltd.提供服务

Scpharmaceuticals Inc.

5.67
0.0000
成交量:- -
成交额:6,179.38万
市值:3.04亿
市盈率:-3.21
高:5.67
开:5.67
低:5.67
收:5.67
52周最高:6.28
52周最低:1.94
股本:5,367.88万
流通股本:3,253.65万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.7677
每股收益(LYR):-1.9126
净资产收益率:-934.02%
总资产收益率:-57.08%
市净率:-14.28
市盈率(LYR):-2.96

数据加载中...

2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/04/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/20

SEC问询函

Form CORRESP - Correspondence
2024/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/13

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/20

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]